Clinical Trials Directory

Trials / Completed

CompletedNCT01864343

Target Temperature Management In Myocardial Infarction - A Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
19 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The primary goal in the treatment of acute myocardial infarction is to reperfuse the ischemic myocardium to reduce infarct size. Animal data and human data suggest that whole-body cooling to temperatures below 35°C before revascularisation can additionally reduce infarct size and therefore improves outcome in these patients. The purpose of the study is to determine the feasibility and safety of a combined cooling strategy started in the out-of-hospital arena for achieving pre-reperfusion hypothermia in patients with acute st-elevation myocardial infarction.

Conditions

Interventions

TypeNameDescription
DEVICEEMCOOLS flex pad; Philips Innercool RTxSurface cooling with EMCOOLS flex pads (out-of-hospital); Infusion of 1000ml to 2000ml of cold saline (out-of-hospital); central-venous cooling (Philips Innercool RTx)

Timeline

Start date
2011-09-01
Primary completion
2013-04-01
Completion
2013-05-01
First posted
2013-05-29
Last updated
2013-05-29

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT01864343. Inclusion in this directory is not an endorsement.